Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis

Showing results (81-90 of 251) with videos related to

Pageof 26
Sort By:
The Prostate|February 2, 2013
Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancerFarshid Dayyani, Andreas Varkaris, John C Araujo, et al.
International Journal of Cancer|March 26, 2013
Ligand-independent activation of MET through IGF-1/IGF-1R signalingAndreas Varkaris, Sanchaika Gaur, Nila U Parikh, et al.
European Urology|July 9, 2015
Metastatic Prostate Cancer and the Bone: Significance and Therapeutic OptionsBenjamin A Gartrell, Robert Coleman, Eleni Efstathiou, et al.
Clinical Genitourinary Cancer|October 10, 2006
Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancerPaul Mathew, Christopher J Logothetis, Pauline Y Dieringer, et al.
The Oncologist|November 18, 2024
Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancerEfstratios Koutroumpakis, Neha Venkatesh, Ana Aparicio, et al.
Carcinogenesis|August 14, 2019
Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African AmericansJunfeng Xu, Wen-Shin Chang, Chia-Wen Tsai, et al.
Cardio-Oncology (London, England)|September 13, 2023
Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experienceAndrew W Hahn, Whittney Thoman, Efstratios Koutroumpakis, et al.
The Prostate|July 21, 2004
Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patientsSara S Strom, Yun Gu, Hui Zhang, et al.
Plos One|December 24, 2011
Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer preventionJin Li, Zhiyong Ding, Zhengxin Wang, et al.
The Journal of Biological Chemistry|June 27, 2006
Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repressionKevin B Spurgers, David L Gold, Kevin R Coombes, et al.
Pageof 26

Showing results (81-90 of 251) with videos related to

Sort By:
Pageof 26
The Prostate|February 2, 2013
Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancerFarshid Dayyani, Andreas Varkaris, John C Araujo, et al.
International Journal of Cancer|March 26, 2013
Ligand-independent activation of MET through IGF-1/IGF-1R signalingAndreas Varkaris, Sanchaika Gaur, Nila U Parikh, et al.
European Urology|July 9, 2015
Metastatic Prostate Cancer and the Bone: Significance and Therapeutic OptionsBenjamin A Gartrell, Robert Coleman, Eleni Efstathiou, et al.
Clinical Genitourinary Cancer|October 10, 2006
Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancerPaul Mathew, Christopher J Logothetis, Pauline Y Dieringer, et al.
The Oncologist|November 18, 2024
Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancerEfstratios Koutroumpakis, Neha Venkatesh, Ana Aparicio, et al.
Carcinogenesis|August 14, 2019
Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African AmericansJunfeng Xu, Wen-Shin Chang, Chia-Wen Tsai, et al.
Cardio-Oncology (London, England)|September 13, 2023
Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experienceAndrew W Hahn, Whittney Thoman, Efstratios Koutroumpakis, et al.
The Prostate|July 21, 2004
Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patientsSara S Strom, Yun Gu, Hui Zhang, et al.
Plos One|December 24, 2011
Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer preventionJin Li, Zhiyong Ding, Zhengxin Wang, et al.
The Journal of Biological Chemistry|June 27, 2006
Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repressionKevin B Spurgers, David L Gold, Kevin R Coombes, et al.
Pageof 26